A retrospective in vitro study of the impact of anti-diabetics and cardioselective pharmaceuticals on breast cancer.

Abstract

The strongest cytotoxic effect was observed with propranolol suggesting that, in clinical practice, this pharmaceutical can be used in patients with breast cancer who have hypertension. A specific clinical recommendation for anti-diabetics is not yet possible.